Crossmark

Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

Crossref DOI link: https://doi.org/10.1007/s13300-018-0400-x

Published Online: 2018-03-16

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karamat, Muhammad Ali http://orcid.org/0000-0001-9808-3841
Dar, Shujah

Bellary, Srikanth

Tahrani, Abd A.
Funding

Funding for this research was provided by:

Novo Nordisk
License Information

Text and Data Mining valid from 2018-03-16
More Information

Article History

Received: 23 January 2018

First Online: 16 March 2018